Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Hansoh Forms $270 Million Partnership with GHDDI for COVID-19 Therapy

publication date: Aug 23, 2022

Shanghai Hansoh Pharma will partner with Beijing’s Global Health Drug Development Center to develop and commercialize the Center’s novel COVID-19 therapy. GDI-4405 is a pre-clinical oral candidate that targets the coronavirus 3CL protease. In pre-clinical tests, GDI-4405 has shown potent inhibition of SARS-CoV-2 replication with good bioavailability and safety. Hansoh will make a $2 million upfront payment, and it will be responsible for up to $268 million in milestones, plus royalties on sales. Formed in 2016, GHDDC is a non-profit organization formed by the Gates Foundation, Tsinghua University and the Beijing Municipal Government. More details....

Stock Symbol: (HK: 3692)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here